152 related articles for article (PubMed ID: 34819131)
1. Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial.
Najafi S; Heidarali Z; Rajabi M; Omidi Z; Zayeri F; Salehi M; Haghighat S
Trials; 2021 Nov; 22(1):835. PubMed ID: 34819131
[TBL] [Abstract][Full Text] [Related]
2. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
[TBL] [Abstract][Full Text] [Related]
3. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
[TBL] [Abstract][Full Text] [Related]
5. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
6. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial).
Kang YJ; Yoon CI; Yang YJ; Baek JM; Kim YS; Jeon YW; Rhu J; Yi JP; Kim D; Oh SJ
BMC Cancer; 2023 Jun; 23(1):570. PubMed ID: 37340369
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.
Kleckner IR; Jusko TA; Culakova E; Chung K; Kleckner AS; Asare M; Inglis JE; Loh KP; Peppone LJ; Miller J; Melnik M; Kasbari S; Ossip D; Mustian KM
Breast Cancer Res Treat; 2021 Sep; 189(2):521-532. PubMed ID: 34191201
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of auricular acupressure for chemotherapy-induced peripheral neuropathy among patients with breast cancer: a study protocol for a randomized controlled trial.
Jung MS; Lee JS; Sohn EH; Cha K; Dlamini NS; Kim M
Ann Palliat Med; 2021 Jan; 10(1):721-732. PubMed ID: 33440985
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study.
Park SJ; Yim GW; Paik H; Lee N; Lee S; Lee M; Kim HS
J Gynecol Oncol; 2021 Sep; 32(5):e73. PubMed ID: 34132071
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer.
Lee KM; Jung D; Hwang H; Son KL; Kim TY; Im SA; Lee KH; Hahm BJ
J Psychosom Res; 2018 May; 108():14-19. PubMed ID: 29602320
[TBL] [Abstract][Full Text] [Related]
12. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
[TBL] [Abstract][Full Text] [Related]
13. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
Bao T; Basal C; Seluzicki C; Li SQ; Seidman AD; Mao JJ
Breast Cancer Res Treat; 2016 Sep; 159(2):327-33. PubMed ID: 27510185
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy.
Song SY; Park JH; Lee JS; Kim JR; Sohn EH; Jung MS; Yoo HS
Integr Cancer Ther; 2020; 19():1534735420925519. PubMed ID: 32493088
[No Abstract] [Full Text] [Related]
15. An evaluation of the effect of lithium on taxane-induced neuropathy.
Kochan DC; Novotny PJ; Cathcart-Rake EJ; Orme JJ; Tevaarwerk AJ; Ruddy KJ; Childs DS
Support Care Cancer; 2023 Apr; 31(5):299. PubMed ID: 37097406
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.
Hershman DL; Unger JM; Crew KD; Minasian LM; Awad D; Moinpour CM; Hansen L; Lew DL; Greenlee H; Fehrenbacher L; Wade JL; Wong SF; Hortobagyi GN; Meyskens FL; Albain KS
J Clin Oncol; 2013 Jul; 31(20):2627-33. PubMed ID: 23733756
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis.
Wu S; Bai X; Guo C; Huang Z; Ouyang H; Huang J; Zeng W
BMC Cancer; 2021 Nov; 21(1):1173. PubMed ID: 34727879
[TBL] [Abstract][Full Text] [Related]
18. The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial).
Joy L; Jolien R; Marithé C; Stijn E; Laura S; Hilde L; Sandra B; Wendy N; Ruth H; Liesbeth R; Sylvana S; Sylvia H; Jeroen M
Support Care Cancer; 2022 Jun; 30(6):5509-5517. PubMed ID: 35312857
[TBL] [Abstract][Full Text] [Related]
19. An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy.
Andersen Hammond E; Pitz M; Steinfeld K; Lambert P; Shay B
Neurorehabil Neural Repair; 2020 Mar; 34(3):235-246. PubMed ID: 31976819
[No Abstract] [Full Text] [Related]
20. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
